- Home
- » Tags
- » Dalotuzumab
Top View
- INN Working Document 05.179 Update December 2010
- IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
- WO 2013/169611 Al 14 November 2013 (14.11.2013) P O P C T
- A Phase I Pharmacokinetic and Pharmacodynamic Study Of
- (INN) for Biological and Biotechnological Substances
- Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies
- 6.6.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
- A Parallel-Arm Phase I Trial of the Humanised Anti-IGF-1R Antibody
- Open Full Page
- WO 2018/183580 Al 04 October 2018 (04.10.2018) W !P O PCT
- Snapshot: Breast Cancer Kornelia Polyak and Otto Metzger Filho Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215 USA
- Anti-IGF-1R Monoclonal Antibody
- Deregulation of the EGFR/PI3K/PTEN/Akt/Mtorc1 Pathway in Breast Cancer: Possibilities for Therapeutic Intervention
- The Example of Lung Cancer Perrine Créquit1,2†, Ludovic Trinquart1,2,3,4*†, Amélie Yavchitz1,2,3 and Philippe Ravaud1,2,3,4,5
- Supplementary Appendix
- 231 Targeting EGFR and IGF 1R
- A Twenty-First Century Cancer Epidemic Caused by Obesity: the Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors
- Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
- Combination Therapy Approaches to Target Insulin-Like Growth Factor Receptor Signaling in Breast Cancer
- Antibody Therapy of Cancer
- Supplementary Tables and Figures Section 1. Distribution of CDR-H3
- Patterns in Target-Directed Breast Cancer Research
- (2006.01) C07d 413/14
- Effects on Cancer Therapy
- (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage Iv Metastatic Non-Squamous Lung Cancer
- Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
- WO 2013/119960 A2 15 August 2013 (15.08.2013) P O P C T
- (INN) for Biological and Biotechnological Substances
- Targeting Obesity-Related Dysfunction in Hormonally Driven Cancers
- A Twenty-First Century Cancer Epidemic Caused by Obesity: the Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors
- Plantillaportadatdx RET Con Diposit UB
- The Role of the Insulin-Like Growth Factor Axis in Osseous Metastasis
- Oncology Drugs in the Pipeline
- Downloaded from Bioscientifica.Com at 09/27/2021 01:39:35AM Via Free Access
- In Hormone-Sensitive Breast Cancer
- Development of Polypeptide-Based Therapeutics for the Treatment of Castration Resistant Prostate Cancer
- Comprehensive Review of Targeted Therapy for Colorectal Cancer
- Differential Effects of IGF-1R Small Molecule Tyrosine Kinase Inhibitors
- Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities
- Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases